中西医结合治疗心肌梗死后缺血再灌注损伤的研究进展
CSTR:
作者:
作者单位:

作者简介:

肖立运,男,副主任医师,主要研究方向是中西医结合治疗心血管病。

通讯作者:

中图分类号:

R 541

基金项目:

济宁市重点研发计划项目(2022YXNS131,2019MNS021);山东省中医药科技发展计划项目(2019-0454)


Research Progress in the Treatment of Ischemia-reperfusion in Jury after Myocardial Infarction with Integrated Traditional Chinese and Western Medicine
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘 要〕 心肌缺血是冠心病的重要病理改变,血流灌注量减少使心肌处于缺血、缺氧状态,导致能量代谢异常,心功 能不同程度的降低等,严重者可诱发心肌梗死、猝死等不良事件。而急性心肌梗死(AMI)后冠心病最为严重的心肌缺血类型, 以胸口疼痛、呼吸困难、胸闷、呕吐为主要临床症状,若不积极治疗,可引发心律失常,增加猝死风险。临床上再灌注治 疗是 AMI 治疗的主要手段,再灌注治疗通过溶栓药物、介入治疗或手术治疗,将完全闭塞的血管重新开通,使缺血组织获 得再灌注。及时的血运重建治疗能够在短时间内恢复血液供应,但同时亦会导致不同程度的缺血再灌注损伤(IRI),损害 心肌的结构和功能,被认为是影响冠心病患者再灌注治疗效果的主要事件。目前研究发现心肌缺血再灌注损伤(MIRI)与 氧化应激、Ca2+ 超载、能量代谢障碍、炎症反应等机制相关。药物治疗着眼于相关机制从而保护心肌缺血再灌注损伤,如 抗氧自由基、抑制钙超载、改善炎症浸润及细胞凋亡、减轻线粒体损伤。目前西医治疗再灌注损伤已处于瓶颈,笔者尝试 引入中医药理论。根据中医观点,AMI 可归于 “ 心痛 ”“ 胸痹 ” 范畴,病位在心,牵连肝、脾、肾等诸多脏器,病机见于气 虚血瘀,宜采用养气除痹、 活血化瘀之法。因而从中西医结合理论深入探索再灌注损伤的发病机制,系统总结再灌注损伤 的中西医可能的主要机制,对于防治缺血再灌注损伤具有重要价值。

    Abstract:

    Abstract〕 Myocardial ischemia is an important pathological change in coronary heart disease. A decrease in blood flow perfusion puts the myocardium in a state of ischemia and hypoxia, leading to abnormal energy metabolism and varying degrees of decreased cardiac function. In severe cases, it can induce adverse events such as myocardial infarction and sudden death. The most severe type of myocardial ischemia after acute myocardial infarction (AMI) is coronary heart disease, with chest pain, breathing difficulties, chest tightness, and vomiting as the main clinical symptoms. If not actively treated, it can cause arrhythmias and increase the risk of sudden death. In clinical practice, reperfusion therapy is the main method of treating AMI. Through thrombolytic drugs, interventional therapy, or surgical treatment, reperfusion therapy reopens completely occluded blood vessels, allowing ischemic tissue to achieve reperfusion. Timely revascularization therapy can restore blood supply in a short period of time, but it can also lead to varying degrees of ischemia-reperfusion injury (IRI), damaging the structure and function of the myocardium, and is considered a major event that affects the effectiveness of reperfusion therapy in patients with coronary heart disease. At present, research has found that myocardial ischemia-reperfusion injury (MIRI) is related to mechanisms such as oxidative stress, Ca2+ overload, energy metabolism disorders, and inflammatory reactions. Drug therapy focuses on relevant mechanisms to protect MIRI, such as combating oxygen free radicals, inhibiting calcium overload, improving inflammatory infiltration and cell apoptosis, and alleviating mitochondrial damage. At present, the treatment of reperfusion injury with Western medicine is at a bottleneck, and the author attempts to introduce the theory of traditional Chinese medicine. According to the perspective of traditional Chinese medicine, AMI can be classified into the categories of "heartache" and "chest obstruction". The disease is located in the heart, involving many organs such as the liver, spleen,and kidney. The pathogenesis is seen in qi deficiency and blood stasis, and it is recommended to use the methods of nourishing qi to remove obstruction and promoting blood circulation to remove stasis. Therefore, exploring the pathogenesis of reperfusion injury from the perspective of integrated traditional Chinese and Western medicine theory and systematically summarizing the possible main mechanisms of reperfusion injury in traditional Chinese and Western medicine is of great clinical significance for the prevention and treatment of IRI.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-12-28
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-07-12
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭